SAN FRANCISCO (AP) _ Twist Bioscience Corp. (TWST) on Wednesday reported a loss of $31.2 million in its fiscal fourth quarter. On a per-share ...
News
- Twist Bioscience: Fiscal 4Q Earnings Snapshot
- USMCA: The 3 most important changes in the new NAFTA and why they matter
The new agreement includes stronger protections for patents and trademarks in areas such as biotech, financial services and domain names – all of ...
- The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks. (Biotech stocks hitting 52-week highs on Dec.
- SABCS: Seattle Genetics hails 'stunning' tucatinib breast cancer data
Seattle Genetics went from ASH to the 2019 San Antonio Breast Cancer Symposium, where it shared detailed data from its pivotal tucatinib trial.
- SABCS: AstraZeneca, Daiichi's ADC keeps breast cancer at bay for 16 months
The data, presented at the San Antonio Breast Cancer Symposium, come from 184 patients with advanced HER2-positive breast cancer who received ...